1. Asthma and Allergy Foundation of America [Internet]. Asthma Facts. [cited 2020 Jan 8]. Available from: https://www.aafa.org/asthma-facts/
2. Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407-418.
3. Spirometry for Asthma [Internet]. Choosing Wisely – Promoting conversations between providers and patients. [cited 2020 Jan 8]. Available from: http://www.choosingwisely.org/patient-resources/spirometry-for-asthma/
4. MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); Asthma; [updated 2019 Nov 12; reviewed 2018 May 17; cited 2020 Jan 8]; [about 4 screens]. Available from: https://medlineplus.gov/asthma.html
5. Fliesler, N. The obesity-asthma connection: A link in the innate immune system. 2017 November 16; Available from https://vector.childrenshospital.org/2013/12/the-obesity-asthma-connection-a-link-in-the-innate-immune-system/
6. Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Respir Med 2000;94:767-71.
7. Aldridge RE, Hancox RJ, Robin Taylor D, Cowan JO, Winn MC, Frampton CM, Town GI. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Respir Crit Care Med 2000;161:1459-64.
8. Stanford RH, Shah MB, D』Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Annals of Allergy, Asthma & Immunology 2012;109:403-7.
9. O'Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N Engl J Med. 2018;378(20):1865-1876.
10. Achakulwisut P, Brauer M, Hystad P, Anenberg SC. Global, national, and urban burdens of paediatric asthma incidence attributable to ambient NO2 pollution: estimates from global datasets. Lancet Planet Health. 2019;3(4):e166-e178.
11. Beasley, R., et al. Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma. New England Journal of Medicine, 2019; 380(21), 2020-2030. doi:10.1056/nejmoa1901963
12. Hardy J, Baggott C, Fingleton J, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial [published correction appears in Lancet. 2020 May 2;395(10234):1422]. Lancet. 2019;394(10202):919-928.
13. Sumino K, Bacharier LB, Taylor J, et al. A Pragmatic Trial of Symptom-Based Inhaled Corticosteroid Use in African-American Children with Mild Asthma. J Allergy Clin Immunol Pract. 2020;8(1):176-185.e2.